Humoral and cellular response of COVID-19 vaccine among solid organ transplant recipients: A systematic review and meta-analysis.
Hari Shankar MeshramVivek B KuteHemant RaneRuchir B DaveSubho BanerjeeVineet MishraSanshriti ChauhanPublished in: Transplant infectious disease : an official journal of the Transplantation Society (2022)
Overall, SOT develops a suboptimal response compared to the general population. Immunosuppression including mycophenolic acid, belatacept, and tacrolimus is associated with decreased response. Booster doses increase the immune response, but further upgradation in vaccination strategy for SOT is required.